查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1865488

全球睡眠呼吸中止症診斷和治療設備市場：預測至2032年－按產品類型、技術、分銷管道、應用、最終用戶和地區分類的分析

Sleep Apnea Diagnostic and Therapeutic Devices Market Forecasts to 2032 - Global Analysis By Product Type (Diagnostic Devices, Therapeutic Devices and Accessories & Consumables), Technology, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的一項研究，全球睡眠呼吸中止症診斷和治療設備市場預計到 2025 年將達到 70 億美元，到 2032 年將達到 133 億美元，在預測期內的複合年成長率為 9.6%。

睡眠呼吸中止症診斷和治療設備是用於檢測、監測和治療睡眠呼吸中止症的醫療技術。睡眠呼吸中止症是一種以睡眠期間反覆呼吸中止為特徵的疾病。診斷設備，例如睡眠多項生理檢查系統、家庭睡眠檢測套組和脈動式血氧監測儀系統，可以記錄氣流、氧濃度和呼吸努力等生理參數，從而識別呼吸中止​​事件。治療設備，包括持續性呼吸道正壓通氣（CPAP）設備、雙水平氣道正壓通氣（BiPAP）設備、口腔矯正器和自適應伺服呼吸機，有助於在睡眠期間保持氣道暢通並穩定呼吸。這些設備在改善睡眠品質、預防併發症和提升整體健康水平方面發揮著重要作用。

睡眠呼吸中止症發生率上升

睡眠呼吸障礙影響全球數百萬人，並導致心血管、神經系統和代謝併發症。此平台支援使用CPAP、BiPAP和穿戴式診斷裝置進行早期檢測、症狀監測和治療遵從性評估。與遠端醫療、人工智慧篩檢和遠端監測的整合提高了服務的可近性和臨床療效。人口老化和高風險族群的增加推動了對擴充性、非侵入性解決方案的需求。這些趨勢正在推動睡眠醫學和慢性病管理生態系統對此平台的廣泛應用。

更高的醫療成本和持續的耗材成本

設備需要初步投資，面罩、導管、過濾器等耗材也需要持續投入，這會對患者的預算造成壓力。報銷缺口和分散的支付方政策進一步加劇了取得和負擔能力的困難。企業在定價模式與臨床療效和病人參與之間保持平衡方面面臨挑戰。供應商必須提供訂閱模式、打包式醫療服務和成本透明的平台，才能提高使用者接受度。這些限制因素持續阻礙著平台在低收入和無保險人口中的普及。

轉向居家檢測和遠端醫療

為了避免診所候診時間並提高便利性，患者越來越傾向於居家睡眠測試和線上諮詢。平台可連接行動應用程式、雲端基礎分析和穿戴式感測器，提供即時洞察和個人化治療。基層醫療、企業健康計劃和保險援助計劃對擴充性且符合隱私保護要求的解決方案的需求日益成長。供應商提供模組化套件、人工智慧驅動的分診和結果儀表板，以支援混合護理模式。這些趨勢正在推動以家庭為中心的數位化睡眠呼吸中止症生態系統的發展。

發展中市場缺乏意識和基礎設施

許多地區缺乏訓練有素的睡眠專家、診斷實驗室和報銷機制，難以支持廣泛的篩檢和治療。文化偏見、健康素養低下以及數位接取受限進一步抑制了需求和參與。企業在向農村和城鄉結合部人口部署可擴展且擴充性的解決方案方面面臨挑戰。供應商必須透過教育宣傳活動、行動優先平台以及對公私合營的投資來擴大其覆蓋範圍。這些限制因素持續限制著服務不足地區和基礎設施有限地區的平台效能。

新冠疫情的感染疾病：

疫情擾亂了全球睡眠診所的診斷流程和治療順從性。封鎖措施延誤了檢查室檢查，並減少了呼吸治療師和睡眠專家的診療機會。疫情後的恢復期，睡眠醫學領域更重視遠距醫療、數位化診斷和病患自我管理。醫療系統和消費者管道對遠端監測、人工智慧篩檢和家庭治療的投資激增。政策制定者和臨床醫生對睡眠健康與免疫力和心理健康之間聯繫的認知也在不斷提高。這些變化支持對去中心化、數位化睡眠呼吸中止症基礎設施進行長期投資。

預計在預測期內，治療器材領域將佔據最大的市場規模。

由於其在治療睡眠呼吸中止症方面的臨床效用、擴充性和廣泛應用，預計治療設備領域將在預測期內佔據最大的市場佔有率。該領域涵蓋CPAP、BiPAP和自動調節設備等平台，這些設備有助於呼吸道管理和緩解症狀。與加濕器整合、數據追蹤和遠端監測功能可提高治療依從性和個人化程度。居家醫療和門診護理機構對緊湊、靜音和便攜設備的需求日益成長。供應商提供模組化配置、雲端連接和病人參與工具，以支持長期治療。這些特性鞏固了該領域在治療睡眠呼吸中止症平台的主導地位。

預計在預測期內，複雜性睡眠呼吸中止症細分市場將呈現最高的複合年成長率。

預計在預測期內，複雜睡眠呼吸中止症領域將迎來最高的成長率，這主要得益於診斷和治療平台在混合型和治療誘髮型睡眠呼吸中止症病例中的應用。這類患者同時表現出阻塞性和中樞性睡眠呼吸中止模式，需要高階監測和適應性治療。相關平台支援多通道診斷、演算法滴定以及跨心臟病學、神經病學和肺病學的綜合護理。與人工智慧引擎、穿戴式感測器和雲端基礎分析的整合提高了診斷的準確性和響應速度。專科診所和三級醫療中心對擴充性且經過臨床檢驗的解決方案的需求日益成長。這些趨勢正在推動複雜睡眠呼吸中止症平台和服務的發展。

佔比最大的地區：

由於醫療基礎設施、報銷體系的進步以及睡眠呼吸中止症技術的臨床應用，預計北美將在預測期內佔據最大的市場佔有率。為了滿足不斷成長的需求，企業和醫療服務提供者正在醫院、居家醫療和企業健康計劃中部署相關平台。對人工智慧診斷、遠端醫療和治療創新的投資有助於擴充性和個人化。主要供應商、學術機構和政策舉措的參與正在推動生態系統的成熟和普及。各公司正在將其睡眠呼吸中止症策略與慢性病管理、價值醫療和數位健康目標結合。

年複合成長率最高的地區：

預計亞太地區在預測期內將實現最高的複合年成長率，這主要得益於都市化、醫療保健現代化以及人們對睡眠障礙認知的不斷提高，這些因素共同推動了該地區的經濟發展。中國、印度、日本和韓國等國家正在拓展其在公共衛生、企業健康和消費者管道的平台。政府支持計畫正在支持睡眠醫學領域的基礎設施建設、數位醫療應用和宣傳宣傳活動。本地醫療服務提供者正在提供經濟高效、符合當地文化且以行動端為先的解決方案，以滿足當地需求。都市區和近郊市場對擴充性且整體性的睡眠呼吸中止症基礎設施的需求日益成長。這些趨勢正在推動該地區睡眠呼吸中止症創新和應用的成長。

免費客製化服務

訂閱本報告的用戶可從以下免費自訂選項中選擇一項：

  • 公司簡介
    • 對最多三家其他公司進行全面分析
    • 對主要企業進行SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶興趣對主要國家進行市場估算、預測和複合年成長率分析（註：基於可行性檢查）
  • 競爭基準化分析
    • 基於產品系列、地域覆蓋和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 引言

  • 概述
  • 相關利益者
  • 分析範圍
  • 分析方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 分析方法
  • 分析材料
    • 原始研究資料
    • 二手研究資訊來源
    • 先決條件

第3章 市場趨勢分析

  • 介紹
  • 促進要素
  • 抑制因素
  • 市場機遇
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 終端用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代產品的威脅
  • 新參與企業的威脅
  • 公司間的競爭

5. 全球睡眠呼吸中止症診斷和治療設備市場（按產品類型分類）

  • 介紹
  • 診斷設備
  • 治療設備
  • 配件和耗材

6. 全球睡眠呼吸中止症診斷和治療設備市場（按技術分類）

  • 介紹
  • 診斷技術
    • 睡眠多項生理檢查（PSG）系統
    • 呼吸多導儀
    • 脈動式血氧監測儀系統
    • 活動記錄儀
    • 人工智慧睡眠監測
    • 雲端基礎的數據分析
  • 治療技術
    • 正壓通氣（PAP）裝置
    • 口腔矯正器
    • ASV (Adaptive Servo-Ventilation)
    • 智慧口罩及配件
    • 加濕器，舒適設備
    • 遠端監控和聯網治療系統

7. 全球睡眠呼吸中止症診斷和治療設備市場（按分銷管道分類）

  • 介紹
  • 醫院藥房
  • 零售藥房
  • 線上平台
  • 直銷

8. 全球睡眠呼吸中止症診斷和治療設備市場（按應用分類）

  • 介紹
  • 阻塞型睡眠呼吸中止症（OSA）
  • 中樞性睡眠呼吸中止症（CSA）
  • 複雜性睡眠呼吸中止症
  • 其他用途

9. 全球睡眠呼吸中止症診斷和治療設備市場（按最終用戶分類）

  • 介紹
  • 醫院
  • 睡眠診所
  • 居家醫療
  • 研究和學術機構
  • 其他最終用戶

第10章 全球睡眠呼吸中止症診斷與治療設備市場（按地區分類）

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章：主要趨勢

  • 合約、商業夥伴關係和合資企業
  • 企業合併（M&A）
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第12章：公司簡介

  • ResMed Inc.
  • Koninklijke Philips NV
  • Fisher & Paykel Healthcare Corporation Limited
  • Drive DeVilbiss Healthcare LLC
  • Compumedics Limited
  • BMC Medical Co. Ltd.
  • SomnoMed Limited
  • Natus Medical Incorporated
  • Itamar Medical Ltd.
  • Braebon Medical Corporation
  • Curative Medical Inc.
  • Lowenstein Medical Technology GmbH+Co. KG
  • Cadwell Industries Inc.
  • Cleveland Medical Devices Inc.
  • AirAvant Medical Inc.
Product Code: SMRC32186

According to Stratistics MRC, the Global Sleep Apnea Diagnostic and Therapeutic Devices Market is accounted for $7.0 billion in 2025 and is expected to reach $13.3 billion by 2032 growing at a CAGR of 9.6% during the forecast period. Sleep apnea diagnostic and therapeutic devices are medical technologies designed to detect, monitor, and treat sleep apnea-a disorder characterized by repeated interruptions in breathing during sleep. Diagnostic devices, such as polysomnography systems, home sleep testing kits, and oximeters, record physiological parameters like airflow, oxygen levels, and respiratory effort to identify apnea episodes. Therapeutic devices, including continuous positive airway pressure (CPAP) machines, bi-level positive airway pressure (BiPAP) devices, oral appliances, and adaptive servo-ventilators, help maintain open airways and ensure proper breathing throughout sleep. These devices play a crucial role in improving sleep quality, preventing complications, and enhancing overall health.

Market Dynamics:

Driver:

Rising prevalence of sleep apnea

Sleep-disordered breathing affects millions globally and contributes to cardiovascular neurological and metabolic complications. Platforms support early detection symptom monitoring and treatment adherence using CPAP BiPAP and wearable diagnostics. Integration with telehealth AI-based screening and remote monitoring enhances accessibility and clinical outcomes. Demand for scalable and non-invasive solutions is rising across aging populations and high-risk cohorts. These dynamics are propelling platform deployment across sleep medicine and chronic disease management ecosystems.

Restraint:

High cost of therapy and ongoing consumable costs

Devices require upfront investment and recurring expenses for masks tubing and filters that strain patient budgets. Reimbursement gaps and fragmented payer policies further complicate access and affordability. Enterprises face challenges in aligning pricing models with clinical outcomes and patient engagement. Vendors must offer subscription models bundled care and cost-transparent platforms to improve uptake. These constraints continue to hinder platform maturity across low-income and underinsured populations.

Opportunity:

Shift to home-based testing and telehealth

Patients increasingly prefer at-home sleep studies and virtual consultations to avoid clinical wait times and improve convenience. Platforms integrate with mobile apps cloud-based analytics and wearable sensors to deliver real-time insights and personalized therapy. Demand for scalable and privacy-compliant solutions is rising across primary care employer wellness and insurance-backed programs. Vendors offer modular kits AI-driven triage and outcome dashboards to support hybrid care models. These trends are fostering growth across home-centric and digitally enabled sleep apnea ecosystems.

Threat:

Limited awareness & infrastructure in developing markets

Many regions lack trained sleep specialists diagnostic labs and reimbursement frameworks to support widespread screening and treatment. Cultural stigma low health literacy and limited digital access further degrade demand and engagement. Enterprises face challenges in deploying scalable and regionally adapted solutions across rural and peri-urban populations. Vendors must invest in education campaigns mobile-first platforms and public-private partnerships to expand reach. These limitations continue to restrict platform performance across underserved and infrastructure-limited geographies.

Covid-19 Impact:

The pandemic disrupted sleep clinics diagnostic workflows and therapy adherence across global markets. Lockdowns delayed in-lab studies and reduced access to respiratory therapists and sleep specialists. Post-pandemic recovery emphasized remote care digital diagnostics and patient self-management across sleep medicine. Investment in telemonitoring AI screening and home-based therapy surged across healthcare systems and consumer channels. Public awareness of sleep health and its link to immunity and mental well-being increased across policy and clinical circles. These shifts are reinforcing long-term investment in decentralized and digitally enabled sleep apnea infrastructure.

The therapeutic devices segment is expected to be the largest during the forecast period

The therapeutic devices segment is expected to account for the largest market share during the forecast period due to their clinical relevance scalability and widespread adoption across sleep apnea treatment. Platforms include CPAP BiPAP and auto-adjusting devices that support airway management and symptom relief. Integration with humidifiers data tracking and remote monitoring enhances adherence and personalization. Demand for compact quiet and travel-friendly devices is rising across homecare and outpatient settings. Vendors offer modular configurations cloud connectivity and patient engagement tools to support long-term therapy. These capabilities are boosting segment dominance across therapeutic sleep apnea platforms.

The complex sleep apnea syndrome segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the complex sleep apnea syndrome segment is predicted to witness the highest growth rate as diagnostic and therapeutic platforms expand across mixed and treatment-emergent apnea cases. Patients exhibit both obstructive and central apnea patterns requiring advanced monitoring and adaptive therapy. Platforms support multi-channel diagnostics algorithmic titration and integrated care across cardiology neurology and pulmonology. Integration with AI engines wearable sensors and cloud-based analytics enhances precision and responsiveness. Demand for scalable and clinically validated solutions is rising across specialty clinics and tertiary care centers. These dynamics are accelerating growth across complex sleep apnea syndrome platforms and services.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share due to its healthcare infrastructure reimbursement frameworks and clinical adoption across sleep apnea technologies. Enterprises and providers deploy platforms across hospitals homecare and employer wellness programs to meet rising demand. Investment in AI diagnostics telehealth and therapeutic innovation supports scalability and personalization. Presence of leading vendors academic institutions and policy initiatives drives ecosystem maturity and adoption. Firms align sleep apnea strategies with chronic disease management value-based care and digital health goals.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR as urbanization healthcare modernization and sleep disorder awareness converge across regional economies. Countries like China India Japan and South Korea scale platforms across public health employer wellness and consumer channels. Government-backed programs support infrastructure development digital health adoption and awareness campaigns across sleep medicine. Local providers offer cost-effective culturally adapted and mobile-first solutions tailored to regional needs. Demand for scalable and inclusive sleep apnea infrastructure is rising across urban and peri-urban markets. These trends are accelerating regional growth across sleep apnea innovation and deployment.

Key players in the market

Some of the key players in Sleep Apnea Diagnostic and Therapeutic Devices Market include ResMed Inc., Koninklijke Philips N.V., Fisher & Paykel Healthcare Corporation Limited, Drive DeVilbiss Healthcare LLC, Compumedics Limited, BMC Medical Co. Ltd., SomnoMed Limited, Natus Medical Incorporated, Itamar Medical Ltd., Braebon Medical Corporation, Curative Medical Inc., Lowenstein Medical Technology GmbH + Co. KG, Cadwell Industries Inc., Cleveland Medical Devices Inc. and AirAvant Medical Inc.

Key Developments:

In October 2025, ResMed entered a joint venture with Google's Verily, aiming to develop software solutions for diagnosing and managing sleep apnea and related breathing disorders. The U.S.-based venture combined ResMed's clinical expertise with Verily's data analytics capabilities to improve early detection and personalized treatment pathways for millions of undiagnosed patients.

In May 2025, - Philips acquired DiA Imaging Analysis, an AI-powered ultrasound software firm, to strengthen its diagnostic imaging capabilities. While not exclusive to sleep apnea, the acquisition supported Philips' broader strategy to integrate AI into multi-modality diagnostics, including respiratory and sleep-related imaging workflows.

Product Types Covered:

  • Diagnostic Devices
  • Therapeutic Devices
  • Accessories & Consumables

Technologies Covered:

  • Diagnostic Technologies
  • Therapeutic Technologies

Distribution Channels Covered:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Platforms
  • Direct Sales

Applications Covered:

  • Obstructive Sleep Apnea (OSA)
  • Central Sleep Apnea (CSA)
  • Complex Sleep Apnea Syndrome
  • Other Applications

End Users Covered:

  • Hospitals
  • Sleep Clinics
  • Homecare Settings
  • Research & Academic Institutions
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Sleep Apnea Diagnostic and Therapeutic Devices Market, By Product Type

  • 5.1 Introduction
  • 5.2 Diagnostic Devices
  • 5.3 Therapeutic Devices
  • 5.4 Accessories & Consumables

6 Global Sleep Apnea Diagnostic and Therapeutic Devices Market, By Technology

  • 6.1 Introduction
  • 6.2 Diagnostic Technologies
    • 6.2.1 Polysomnography (PSG) Systems
    • 6.2.2 Respiratory Polygraphs
    • 6.2.3 Pulse Oximeters
    • 6.2.4 Actigraphy Devices
    • 6.2.5 AI-Enabled Sleep Monitoring
    • 6.2.6 Cloud-Based Data Analytics
  • 6.3 Therapeutic Technologies
    • 6.3.1 Positive Airway Pressure (PAP) Devices
    • 6.3.2 Oral Appliances
    • 6.3.3 Adaptive Servo-Ventilation (ASV)
    • 6.3.4 Smart Masks & Accessories
    • 6.3.5 Humidifiers and Comfort Devices
    • 6.3.6 Telemonitoring and Connected Therapy Systems

7 Global Sleep Apnea Diagnostic and Therapeutic Devices Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Hospital Pharmacies
  • 7.3 Retail Pharmacies
  • 7.4 Online Platforms
  • 7.5 Direct Sales

8 Global Sleep Apnea Diagnostic and Therapeutic Devices Market, By Application

  • 8.1 Introduction
  • 8.2 Obstructive Sleep Apnea (OSA)
  • 8.3 Central Sleep Apnea (CSA)
  • 8.4 Complex Sleep Apnea Syndrome
  • 8.5 Other Applications

9 Global Sleep Apnea Diagnostic and Therapeutic Devices Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Sleep Clinics
  • 9.4 Homecare Settings
  • 9.5 Research & Academic Institutions
  • 9.6 Other End Users

10 Global Sleep Apnea Diagnostic and Therapeutic Devices Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 ResMed Inc.
  • 12.2 Koninklijke Philips N.V.
  • 12.3 Fisher & Paykel Healthcare Corporation Limited
  • 12.4 Drive DeVilbiss Healthcare LLC
  • 12.5 Compumedics Limited
  • 12.6 BMC Medical Co. Ltd.
  • 12.7 SomnoMed Limited
  • 12.8 Natus Medical Incorporated
  • 12.9 Itamar Medical Ltd.
  • 12.10 Braebon Medical Corporation
  • 12.11 Curative Medical Inc.
  • 12.12 Lowenstein Medical Technology GmbH + Co. KG
  • 12.13 Cadwell Industries Inc.
  • 12.14 Cleveland Medical Devices Inc.
  • 12.15 AirAvant Medical Inc.

List of Tables

  • Table 1 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Product Type (2024-2032) ($MN)
  • Table 3 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Diagnostic Devices (2024-2032) ($MN)
  • Table 4 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Therapeutic Devices (2024-2032) ($MN)
  • Table 5 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Accessories & Consumables (2024-2032) ($MN)
  • Table 6 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Technology (2024-2032) ($MN)
  • Table 7 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Diagnostic Technologies (2024-2032) ($MN)
  • Table 8 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Polysomnography (PSG) Systems (2024-2032) ($MN)
  • Table 9 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Respiratory Polygraphs (2024-2032) ($MN)
  • Table 10 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Pulse Oximeters (2024-2032) ($MN)
  • Table 11 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Actigraphy Devices (2024-2032) ($MN)
  • Table 12 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By AI-Enabled Sleep Monitoring (2024-2032) ($MN)
  • Table 13 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Cloud-Based Data Analytics (2024-2032) ($MN)
  • Table 14 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Therapeutic Technologies (2024-2032) ($MN)
  • Table 15 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Positive Airway Pressure (PAP) Devices (2024-2032) ($MN)
  • Table 16 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Oral Appliances (2024-2032) ($MN)
  • Table 17 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Adaptive Servo-Ventilation (ASV) (2024-2032) ($MN)
  • Table 18 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Smart Masks & Accessories (2024-2032) ($MN)
  • Table 19 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Humidifiers and Comfort Devices (2024-2032) ($MN)
  • Table 20 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Telemonitoring and Connected Therapy Systems (2024-2032) ($MN)
  • Table 21 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 22 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Hospital Pharmacies (2024-2032) ($MN)
  • Table 23 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Retail Pharmacies (2024-2032) ($MN)
  • Table 24 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Online Platforms (2024-2032) ($MN)
  • Table 25 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Direct Sales (2024-2032) ($MN)
  • Table 26 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Application (2024-2032) ($MN)
  • Table 27 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Obstructive Sleep Apnea (OSA) (2024-2032) ($MN)
  • Table 28 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Central Sleep Apnea (CSA) (2024-2032) ($MN)
  • Table 29 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Complex Sleep Apnea Syndrome (2024-2032) ($MN)
  • Table 30 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 31 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By End User (2024-2032) ($MN)
  • Table 32 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 33 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Sleep Clinics (2024-2032) ($MN)
  • Table 34 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Homecare Settings (2024-2032) ($MN)
  • Table 35 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Research & Academic Institutions (2024-2032) ($MN)
  • Table 36 Global Sleep Apnea Diagnostic and Therapeutic Devices Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.